The AHA and its members are partnering with the Department of Health and Human Services to encourage eligible patients who recover from COVID-19 to donate convalescent plasma, which contains antibodies that could help other patients fight the virus.

According to recent findings from the Food and Drug Administration’s Expanded Access Program for COVID-19, a study of the first 20,000 adults hospitalized with severe or life-threatening COVID-19 to receive convalescent plasma found the investigational therapy safe in diverse patients.

For more on donating COVID-19 convalescent plasma, visit the FDA’s webpage on donation.

Related News Articles

Headline
The Food and Drug Administration yesterday released FAQs describing the procedures for importing respirators, face masks, and other personal protective…
Headline
The departments of Health and Human Services and Defense will pay Moderna Inc. about $1.5 billion to produce and deliver 100 million doses of its COVID-19…
Headline
The Department of Health and Human Services yesterday announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund…
Headline
Houston’s Kindred Healthcare and TIRR Memorial Hermann are among the many post-acute care providers that have incurred increased costs to prepare for and treat…
Headline
The Food and Drug Administration Friday authorized the emergency use of George Washington University Public Health Laboratory’s GWU SARS-CoV-2 RT-PCR Test. The…
Headline
Researchers have launched two clinical trials to test whether monoclonal (laboratory-made) antibodies can safely prevent SARS-CoV-2 infection or symptoms in…